10 Low Volatility Stocks to Buy According to Billionaire Ken Fisher

2. Eli Lilly and Company (NYSE:LLY)

Beta Value: 0.49

Dividend Yield: 0.72%

Fisher Asset Management’s Q4 Stake: $4.04 billion

Number of Hedge Fund Holders: 115

Eli Lilly & Company (NYSE:LLY) is a major global pharmaceutical company that develops, manufactures, and distributes a wide range of drugs. Founded in 1876, it has grown to become one of the world’s largest pharmaceutical companies.

Bernstein SocGen Group maintained a favorable view for Eli Lilly & Company (NYSE:LLY) shares on March 18, confirming an Outperform rating and a $1,100 price target. The update follows recent pre-clinical data published on March 14th, which shows Eli Lilly’s Retatrutide having great potential for lowering tumor development and cancer risk, especially in lung and pancreatic cancer models in mice. Bernstein analyst Courtney Breen stressed the significance of this study, noting its possible implications for the variety of health outcomes possible with incretin-based anti-obesity drugs.

In the fourth quarter of 2024, the company’s revenues jumped by 45% to $13.53 billion, owing to increasing demand for Mounjaro and Zepbound. while earnings per share rose massively by 102% to $4.88.